[1]杜兴祥,翁俊飞,肖群林,等.左右心室电极间距离指导心脏再同步化治疗临床效果和安全性[J].介入放射学杂志,2021,30(04):331-335.
 DU Xingxiang,WENG Junfei,XIAO Qunlin,et al.The clinical effect and safety of cardiac resynchronization therapy guided by the interlead distance between left and right ventricular electrodes [J].journal interventional radiology,2021,30(04):331-335.
点击复制

左右心室电极间距离指导心脏再同步化治疗临床效果和安全性()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年04
页码:
331-335
栏目:
心脏介入
出版日期:
2021-05-04

文章信息/Info

Title:
The clinical effect and safety of cardiac resynchronization therapy guided by the interlead distance between left and right ventricular electrodes
作者:
杜兴祥 翁俊飞 肖群林 董 薇 黄伟林 王志超 刘 茜 彭景添 郑泽琪 彭小平
Author(s):
DU Xingxiang WENG Junfei XIAO Qunlin DONG Wei HUANG Weilin WANG Zhichao LIU Qian PENG Jingtian ZHENG Zeqi PENG Xiaoping.
Department of Cardiology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China
关键词:
【关键词】 左右心室电极间距离 心力衰竭 心脏再同步化治疗 安全性
文献标志码:
A
摘要:
【摘要】 目的 探究左右心室电极间距离(DD)指导心脏再同步化治疗(CRT)的有效性和安全性。 方法 选取2018年5月至2020年1月在南昌大学第一附属医院经最佳药物治疗并接受DD指导CRT的心力衰竭(心衰)患者34例作为观察组,既往研究中接受常规CRT心衰患者75例作为对照组。术后CRT影像资料获取:二维影像上用游标卡尺测量正位时心脏横径(L),分别在正位、左前斜位、右前斜位时测得DD并取最大值,计算DD/L;记录左前斜40°、右前斜30°投影下左心室和右心室电极植入位置。参照《心血管系统疗效评价指标》和meta分析疗效评价标准,CRT临床效果分为显效应答、有效应答和无应答。分析两组患者随访期因心衰再入院次数、全因病死例数。结果 观察组患者CRT应答总有效率略高于对照组(94.1% 对89.3%,P=0.721),CRT显效应答率显著高于对照组(29.4%对9.3%,P=0.007)。观察组、对照组患者随访期因心衰再入院次数分别为2次、13 次,全因病死例数分别为0例、5例。观察组DD、DD/L与对照组相比显著提高(P<0.001)。观察组左心室电极位于基底部位比例高于对照组(70.0%对18.0%,P<0.05),位于前外侧壁比例也高于对照组(46.7%对19.7%,P=0.007)。右心室心尖部起搏右心室时,左心室电极位于前外侧壁和基底部可获得较高的DD、DD/L;右心室室间隔中部起搏右心室时,左心室电极位于后外侧壁与较高的DD相关。结论 DD指导CRT安全性高,可提高CRT总体应答率。

参考文献/References:

[1] Linde C, Mealing S, Hawkins N, et al. Cost- effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE(Resynchronization Reverses remodeling in Systolic Left V entricular Dysfunction)[J]. Eur Heart J, 2011, 32:1631- 1639.
[2] Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction[J]. N Engl J Med, 2013, 368: 1585- 1593.
[3] European Heart Rhythm Association(EHRA), European Society of Cardiology(ESC), Heart Rhythm Society. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow- up recommendations and management[J]. Europace, 2012, 14:1236- 1286.
[4] Naqvi SY, Jawaid A, Goldenberg I, et al. Non- response to cardiac resynchronization therapy[J]. Curr Heart Fail Rep, 2018, 15: 315- 321.
[5] Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular Lead placement to guide cardiac resynchronization therapy the TARGET study: a randomized, controlled trial[J]. J Am Coll Cardiol, 2012, 59: 1509- 1518.
[6] Saba S, Marek J, Schwartzman D, et al. Echocardiography- guided left ventricular Lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchroni-zation Therapy for Electrode Region trial[J]. Circ Heart Fail, 2013, 6: 427- 434.
[7] Kockova R, Sedlacek K, Wichterle D, et al. Cardiac resynchro-nization therapy guided by cardiac magnetic resonance imaging: a prospective, single- centre randomized study(CMR- CRT)[J]. Int J Cardiol, 2018, 270: 325- 330.
[8] Bongiorni MG, Marinskis G, Lip GYH, et al. How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey[J]. Europace, 2012, 14: 1666- 1669.
[9] Clementy N, Laborie G, Pierre B, et al. Three- dimensional interlead distance predicts response and outcomes after cardiac resynchronization therapy[J]. Arch Cardiovasc Dis, 2017, 110: 590- 598.
[10] Ariga R, Tayebjee MH, Benfield A, et al. Greater three- dimensional ventricular lead tip separation is associated with improved outcome after cardiac resynchronization therapy[J]. Pacing Clin Electrophysiol, 2010, 33: 1490- 1496.
[11] 肖群林,刘诗文,董 薇,等. 心脏再同步治疗中左右心室电极位置间距离与临床效果分析[J]. 介入放射学杂志, 2018, 27:303- 308.
[12] Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy:the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association[J]. Eur Heart J, 2007, 28: 2256- 2295.
[13] Kolb C, Tzeis S, Andrikopoulos G, et al. Rationale and design of the SPICE study- septal positioning of ventricular ICD electrodes[J]. J Interv Card Electrophysiol, 2011, 31: 247- 254.
[14] Hsu JC, Solomon SD, Bourgoun M, et al. Predictors of super- response to cardiac resynchronization therapy and associated improvement in clinical outcome the MADIT- CRT(multicenter automatic defibrillator implantation trial with cardiac resynchro-nization therapy) study[J]. J Am Coll Cardiol, 2012, 59: 2366- 2373.
[15] McMurray JJ, Packer M, Desai AS, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure[J]. N Engl J Med, 2014, 371: 993- 1004.
[16] Nassif ME, Windsor SL, Tang F, et al. Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE- HF trial[J]. Circulation, 2019, 140: 1463- 1476.
[17] 于海波,梁延春.心脏再同步化治疗中的右室电极位置选择[J]. 中国心脏起搏与心电生理杂志, 2015, 29:251- 253.
[18] Algazzar AS, Elbably MM, Katta AA, et al. Merits of different ventricular lead locations on left ventricular myocardial strain and dyssynchrony in patients with cardiac resynchronization therapy[J]. Cardiology, 2020, 145: 13- 20.
[19] Miranda RI, Nault M, Johri A, et al. Maximal electric separation- guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy[J]. Circ Arrhythm Electrophysiol, 2012, 5: 927- 932.
[20] Garg J, Chaudhary R, Shah N, et al. Right ventricular apical versus non- apical implantable cardioverter defibrillator lead: a systematic review and meta- analysis[J]. J Electrocardiol, 2017, 50: 591- 597.
[21] Kristiansen HM, Vollan G, Hovstad T, et al. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy[J]. Eur J Heart Fail, 2012, 14: 506- 516.
[22] Kutyifa V, Bloch Thomsen PE,Huang DT, et al. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT- D[J]. Heart Rhythm, 2013, 10: 1770- 1777.
[23] Asbach S, Lennerz C, Semmler V, et al. Impact of the right ventricular lead position on clinical end points in CRT Recipients: a subanalysis of the multicenter randomized SPICE trial[J]. Pacing Clin Electrophysiol, 2016, 39: 261- 267.
[24] Leclercq C, Sadoul N, Mont L, et al. Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators:the SEPTAL CRT study[J]. Eur Heart J, 2016, 37: 473- 483.
[25] Zografos TA, Siontis KC, Jastrzebski M, et al. Apical vs. non- apical right ventricular pacing in cardiac resynchronization therapy: a meta- analysis[J]. Europace, 2015, 17: 1259- 1266.
[26] Daimee UA, Klein HU, Giudici MC, et al. Right ventricular lead location, right- left ventricular lead interaction, and long- term outcomes in cardiac resynchronization therapy patients[J]. J Interv Card Electrophysiol, 2018, 52: 185- 194.
[27] Heist EK, Fan D, Mela T, et al. Radiographic left ventricular- right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy[J]. Am J Cardiol, 2005, 96: 685- 690.
[28] Weigand S, Karl M, Brkic A, et al. The impact of multipole pacing on left ventricular function in patients with cardiac resyn-chronization therapy: a real- time three- dimensional echocar-diography approach[J]. Int J Cardiol, 2018, 272: 238- 243.

相似文献/References:

[1]朱天宇,朱政斌,丁风华,等.国产左心室隔离装置治疗左心室壁瘤动物实验研究[J].介入放射学杂志,2016,(09):803.
 ZHU Tian- yu,ZHU Zheng- bin,DING Feng- hua,et al.Domestic left ventricular partitioning device for the treatment of left ventricular aneurysm: an experimental study in animals[J].journal interventional radiology,2016,(04):803.
[2]杨 伟,刘宗军,郜俊清,等.慢性重度心力衰竭伴窄QRS波患者去肾交感神经术1年疗效 [J].介入放射学杂志,2018,27(06):500.
 YANG Wei,LIU Zongjun,GAO Junqing,et al.Renal sympathetic denervation for patients with chronic severe heart failure and concomitant narrow QRS complex: observation of one- year curative effect[J].journal interventional radiology,2018,27(04):500.
[3]翁俊飞,董 薇,刘雷雷,等.左心室多位点起搏在非特异性室内传导阻滞伴低射血分数心力衰竭患者治疗中的应用[J].介入放射学杂志,2022,31(01):14.
 WENG Junfei,DONG Wei,LIU Leilei,et al.The application of left ventricular multipoint pacing in patients with heart failure complicated by nonspecific intraventricular block and reduced left ventricular ejection fraction[J].journal interventional radiology,2022,31(04):14.
[4]刘雷雷,董 薇,翁俊飞,等.3D打印技术指导心脏再同步化治疗中左右心室电极的定位1例[J].介入放射学杂志,2022,31(07):715.
 LIU Leilei,DONG Wei,WENG Junfei,et al.Application of 3D printing technology in guiding the positioning of right and left ventricular electrodes in performing cardiac resynchronization therapy: report of one case[J].journal interventional radiology,2022,31(04):715.
[5]张 芝,汤学超.心房分流器治疗心力衰竭机制及研究进展[J].介入放射学杂志,2023,32(06):612.
 ZHANG Zhi,TANG Xuechao..Mechanism of atrial shunt device for the treatment of heart failure and its research progress[J].journal interventional radiology,2023,32(04):612.
[6]梁玉佳,吴 强.联合应用多种技术指导左心室起搏电极植入部位的研究[J].介入放射学杂志,2023,32(08):825.
 LIANG Yujia,WU Qiang..Application of combination use of multiple techniques in guiding implantation site of left ventricular pacing electrode[J].journal interventional radiology,2023,32(04):825.

备注/Memo

备注/Memo:
(收稿日期:2020- 09- 14)
(本文编辑:边 佶)
更新日期/Last Update: 2021-04-30